This is a routine governance extension of NOL poison pill with a 3-year term. No material change to OPT's fundamentals or equity value; the lower purchase price ($2.25 from $4) and increased share reserve are technical provisions. Monitor the 2026 annual meeting for stockholder ratification outcome, but no trading catalyst expected from this filing alone.
Price Chart
Executive Summary
OPT adopted an Amended and Restated Section 382 Tax Benefits Preservation Plan (2026-2029) to extend the NOL preservation poison pill from June 29, 2026 to June 29, 2029, reduce the purchase price from $4 to $2.25 per unit, and increase the authorized Series A Preferred Stock reserve to 700,000 shares. The plan deters any single investor (4.99% trigger) from accumulating voting stock without board approval to prevent a Section 382 ownership change that would impair OPT's net operating loss carryforwards.
Key Facts
- Amended and restated Section 382 Tax Benefits Preservation Plan extends from June 29, 2026 to June 29, 2029 (three-year extension).
- Rights purchase price reduced from $4 to $2.25 per Unit.
- Authorized Series A Participating Preferred Stock increased from 100,000 to 700,000 shares.
- Acquiring Person threshold remains at 4.99% beneficial ownership of common stock.
- Board unanimously approved the amendment; seeks stockholder ratification at 2026 Annual Meeting.
- No financial terms, earnings data, or deal value disclosed; purely a defensive governance measure.
Financial Impact
No immediate financial impact; preserves NOL tax assets of undisclosed size by deterring stock accumulation events
Risk Factors
- If stockholder ratification fails at 2026 annual meeting, plan could be voided, exposing NOLs to ownership change risk
- No anti-dilution or fundamental rights benefit for common stockholders from this plan
- Plan could deter legitimate takeover interest that might offer premium to shareholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-030434 |
| Exhibit: ex3-1.htm | 0001493152-26-030434 |
| Exhibit: ex99-1.htm | 0001493152-26-030434 |
| Document: form8-k.htm | 0001493152-26-030434 |
| Document: 0001493152-26-030434-index-headers.html | 0001493152-26-030434 |
| Document: 0001493152-26-030434-index.html | 0001493152-26-030434 |
| Document: 0001493152-26-030434.txt | 0001493152-26-030434 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | Press Release | $0.6824 | awaiting T+5 | — | $0.6410 (−6.07%) |
Oct 15, 2026 12d ago | EFFECT | $0.6878 $0.6496 | ▼ −5.55% | ▼ −4.54% | $0.6410 (−6.80%) |
Oct 14, 2026 12d ago | 424B5 | $0.6878 $0.6496 | ▲ +5.55% | ▲ +4.54% | $0.6410 (+6.80%) |
Oct 7, 2026 19d ago | 8-K/A | $0.9001 $0.6878 | ▼ −23.59% | ▼ −23.31% | $0.6410 (−28.79%) |
Oct 6, 2026 20d ago | 8-K | $0.9600 $0.6600 | ▼ −31.25% | ▼ −30.27% | $0.6410 (−33.23%) |
Sep 25, 2026 4w ago | S-1/A | $1.67 $0.9594 | ▼ −42.55% | ▼ −43.76% | $0.6410 (−61.62%) |
Sep 25, 2026 4w ago | 8-K | $1.67 $0.9594 | ▲ +42.55% | ▲ +43.76% | $0.6410 (+61.62%) |
Sep 11, 2026 6w ago | 8-K | $0.1065 $2.11 | ▲ +1881.22% | ▲ +1881.56% | $0.6410 (+501.88%) |
Aug 24, 2026 9w ago | 8-K | $0.1815 $0.1732 | ▲ +4.57% | ▲ +5.04% | $0.6410 (−253.17%) |
Aug 21, 2026 9w ago | Press Release | $0.1815 $0.1732 | ▲ +4.57% | ▲ +5.04% | $0.6410 (−253.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers